Document is current
Any future updates will be listed below
-
Authors
Bosco, Savana
Peng, Amy
Tuite, Ashleigh R.
Simmons, Alison
Fisman, David N.
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (OV4-170360, OV4-170360, OV4-170360, OV4-170360, OV4-170360)
R. Howard Webster Foundation
- License Information
-
More Information
Article History
Received: 20 December 2024
Accepted: 14 April 2025
First Online: 23 April 2025
Declarations
:
: Approved by the University of Toronto Research Ethics Board, Protocols #39239, #39253 and #44787. Consent to participate: Not applicable, as the study involved secondary analysis of aggregate surveillance data. This study adhered to the Declaration of Helsinki.
: Not applicable (the manuscript contains no individually identifiable images or personal data).
: DNF has served on advisory boards related to influenza and SARS-CoV-2 vaccines for Seqirus, Pfizer, Astrazeneca and Sanofi-Pasteur Vaccines, and has served as a legal expert on issues related to COVID-19 epidemiology for the Elementary Teachers Federation of Ontario and the Registered Nurses Association of Ontario. ART was employed by the Public Health Agency of Canada when the research was conducted. The work does not represent the views of the Public Health Agency of Canada. Other authors: no competing interests.
